An Assessment of Statin Safety by Hepatologists

David E. Cohen, Frank A. Anania, Naga Chalasani

Research output: Contribution to journalArticle

279 Citations (Scopus)

Abstract

The purpose of the Liver Expert Panel was to provide advice to the National Lipid Association's (NLA) Safety Task Force in response to specific questions concerning liver-associated risks of statin therapy. The panel was composed of academic hepatologists with clinical and research interests in nonalcoholic fatty liver disease, lipid metabolic disorders, and drug hepatotoxicity.

Original languageEnglish
JournalThe American Journal of Cardiology
Volume97
Issue number8 SUPPL. 1
DOIs
StatePublished - Apr 17 2006

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids
Safety
Liver
Advisory Committees
Research
Pharmaceutical Preparations
Gastroenterologists
Therapeutics
Non-alcoholic Fatty Liver Disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

An Assessment of Statin Safety by Hepatologists. / Cohen, David E.; Anania, Frank A.; Chalasani, Naga.

In: The American Journal of Cardiology, Vol. 97, No. 8 SUPPL. 1, 17.04.2006.

Research output: Contribution to journalArticle

Cohen, David E. ; Anania, Frank A. ; Chalasani, Naga. / An Assessment of Statin Safety by Hepatologists. In: The American Journal of Cardiology. 2006 ; Vol. 97, No. 8 SUPPL. 1.
@article{81b3249962f24def9a13626621271634,
title = "An Assessment of Statin Safety by Hepatologists",
abstract = "The purpose of the Liver Expert Panel was to provide advice to the National Lipid Association's (NLA) Safety Task Force in response to specific questions concerning liver-associated risks of statin therapy. The panel was composed of academic hepatologists with clinical and research interests in nonalcoholic fatty liver disease, lipid metabolic disorders, and drug hepatotoxicity.",
author = "Cohen, {David E.} and Anania, {Frank A.} and Naga Chalasani",
year = "2006",
month = "4",
day = "17",
doi = "10.1016/j.amjcard.2005.12.014",
language = "English",
volume = "97",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "8 SUPPL. 1",

}

TY - JOUR

T1 - An Assessment of Statin Safety by Hepatologists

AU - Cohen, David E.

AU - Anania, Frank A.

AU - Chalasani, Naga

PY - 2006/4/17

Y1 - 2006/4/17

N2 - The purpose of the Liver Expert Panel was to provide advice to the National Lipid Association's (NLA) Safety Task Force in response to specific questions concerning liver-associated risks of statin therapy. The panel was composed of academic hepatologists with clinical and research interests in nonalcoholic fatty liver disease, lipid metabolic disorders, and drug hepatotoxicity.

AB - The purpose of the Liver Expert Panel was to provide advice to the National Lipid Association's (NLA) Safety Task Force in response to specific questions concerning liver-associated risks of statin therapy. The panel was composed of academic hepatologists with clinical and research interests in nonalcoholic fatty liver disease, lipid metabolic disorders, and drug hepatotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=33645888317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645888317&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.12.014

DO - 10.1016/j.amjcard.2005.12.014

M3 - Article

C2 - 16581333

AN - SCOPUS:33645888317

VL - 97

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 8 SUPPL. 1

ER -